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Available online 8 January 2016AbstractObjective: To evaluate the changes of pulmonary tuberculosis in diabetic and non-diabetic patients by CT scanning before and after anti-
tuberculous therapy.
Methods: Chest CT scans in 71 adult patients with active post primary tuberculosis were reviewed. Among them, 41 had no underlying disease,
but 30 were diagnosed with diabetes mellitus. CT scans were performed before and after anti-tuberculous therapy. The initial CT findings as well
as the findings in follow-up re-examinations were compared. Statistical analysis was performed using SPSS version 17.0 and p value < 0.05 was
considered to be statistically significant.
Results: Compared to non-diabetic patients, the diabetic patients showed a higher detection rate of lesions at the lower lung lobe (30.0% vs
17.1%; P < 0.05), non-segmental consolidation (26.7% vs 2.4%; P < 0.01), singular or multiple cavities within lesion (50.0% vs 30.7%;
P < 0.01). However, the bud-in-tree sign (43.3% vs 61.3%), consolidation (76.6% vs 68.3%), nodules (63.3% vs 73.2%), ground glass opacity
(16.7% vs 24.2%) and bronchiectasis (33.3% vs 41.7%) showed no statistical significance ( p > 0.05). After 6 month anti-tuberculous therapy,
the detection rate of most of the lesions by CT, such as consolidation, nodules, bud-in-tree sign, singular and multiple cavities, and pleural
effusion, showed statistical significance ( p < 0.05). But the diabetic patients had a slower and not obvious therapeutic response by CT scans.
Conclusion: CT findings of tuberculosis in diabetic patients are different from those in non-diabetic patients, with a higher occurrence of non-
segmental distribution and multiple cavities within a tuberculous lesion. By follow-up re-examination, diabetic patients show a slower and
unobvious therapeutic response on CT scans compared to non-diabetic patients. CT can provide important information for the diagnosis and
management of TB in diabetic and non-diabetic patients.
© 2016 Beijing You’an Hospital affiliated to Capital Medical University. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The relationship between diabetes mellitus (DM) and pul-
monary tuberculosis has attracted the interest of many clini-
cians and researchers for a long time. Many studies have* Corresponding author.
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in diabetic patients than in non-diabetic population [1,2].
However, few research findings provide evidence demon-
strating whether DM affects the diagnostic findings of
tuberculosis.
The most common type of pulmonary tuberculosis in adults
is post primary tuberculosis whose lesions are the most
commonly found at the apical and posterior segments of the
upper lung lobes and the superior segments of the lower lung
lobes. Due to data from the field of public health and the advent. Production and hosting by Elsevier B.V. This is an open access article under
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tuberculosis in childhood has been increasing, which further
causes an increased likelihood of tuberculosis during adult-
hood. Therefore, tuberculosis in adults is initially detected as
primary tuberculosis, just the same as that in children. Primary
tuberculosis is commonly diagnosed in association with lobar
pneumonia and hilar/mediastinal lymphadenectasis. The le-
sions of primary tuberculosis in the lungs are commonly located
at the sites with favorable ventilation, such as the middle lung
lobes, the lower lung lobes, and the anterior segment of upper
lung lobe. The radiographic manifestations of tuberculosis in
diabetic patients may differ from the findings in non-diabetic
controls, as was initially reported by Sosman and Steidl [3].
They reported a higher rate of lower lung field (LLF) involve-
ment in their diabetic patients. Other following studies reported
the rate of LLF involvement ranges from 3.4 to 32.2% [4e6].
And these observations were inconsistent to the results from
more recent reports [6,7], with findings of higher prevalence of
multi-lobar involvement and cavitary disease [7,8]. Therefore, a
definitive conclusion is far from being drawn due to the varying
findings in the reported studies.
In the present study, we analyzed the lesions detected by
CT scans in patients with active pulmonary tuberculosis.
Meanwhile we paid focused attention on the differences in the
pattern and distribution of lesions in diabetic patients, which
were compared to those demonstrated in patients without
underlying diseases. And the changes before and after anti-
tuberculous therapy demonstrated by CT scans were also
reviewed and compared.
2. Methods2.1. SubjectsThe present study enrolled 71 consecutive adult patients
with pulmonary tuberculosis. Among them, 41 had no un-
derlying disease including 28 males and 13 females who aged
15e82 years with a mean of 37 ± 8 years, the other 30 had
DM including 19 males and 11 females who aged 28e90 years
with a mean of 59 ± 12 years. The subjects were included in
the DM group if they had a previous history of DM and had
been receiving insulin and/or an oral hypoglycemic agent at
the time of hospitalization or were found with a random blood
glucose of 11.1 mmol/L (200 mg/dl) or a fasting glucose of
7.0 mmol/L (126 mg/dl), postprandial 2 h glucose (OGTT
test) of 11.1 mmol/L (200 mg/dl) and were thus started on
anti-diabetic treatment. A group of 41 cases, who showed no
medical history of DM, was chosen as the control group. None
of the patients in the study or control groups was HIV-positive.
Patients who had been receiving immunosuppressive treatment
or corticosteroids during the 6 months preceding the diagnosis
of tuberculosis were excluded from our analysis.2.2. CT scanRadiological assessment was based on chest CT scanning.
CT scans were obtained with a Philips brilliance CT 16-slice,a Hitachi Pronto CT system and with settings of 10-mm
collimation and 10-mm intervals. More than two thirds of
the lesions were scanned with high resolution CT (HRCT).
Retrospective analysis was performed as follows: (1) analysis
of CT findings (before treatment, after 3 and 6 months treat-
ment) in patients with no underlying disease; (2) analysis of
CT findings (before treatment, after 3 and 6 months treatment)
in diabetic patients; (3) comparison of CT findings (before
treatment, after 3 and 6 months treatment) in diabetic patients
with those in patients without underlying disease. All abnor-
malities including lymphadenopathy and pleural effusion were
assessed. When the lesions extended to one or more segments
of the lung, the lesions were believed to have spread trans-
bronchogenically, and a diagnosis of segmental distribution
was made. Other indicators for CT characterizations also
included the presence of infiltrates, cavities, centrilobular le-
sions, the bud-in-tree sign, micro-nodules of 5 mm in
diameter, bronchiectasis, pleural effusion, mediastinal
lymphadenopathy, hilar lymphadenopathy, bilaterally or
unilaterally affected lung (right, left or both), and the affected
lung lobe (upper, middle or lower).2.3. Anti-tuberculous treatmentThe anti-tuberculous treatment regimen was conventionally
administered, with an initial therapeutic course of isoniazid,
rifampin, pyrazinamide, and streptomycin or ethambutol daily
for 3 months followed by isoniazid and rifampin for 6 months.2.4. Statistical analysisResults of both groups were compared and analyzed. Sta-
tistical analysis was performed using Statistical Package for
Social Sciences (SPSS) version 17.0. Chi-square test was
performed to analyze the group differences. A p value of
<0.05 was considered to be statistically significant.
3. Results3.1. General appearancesThe ratio of male to female in the TB DM group was lower
than that in the TB group (p < 0.05). The TB group consisted
of almost twice as many as males than females, whereas in the
TB DM group, the ratio was close to 1. The patients from TB
DM group were significantly elder (mean age 59 ± 12 yr;
range 28e90 yr) than the patients from TB group (mean age
37 ± 8 yr; range 15e82 yr; p < 0.01).
The incidence of clinical symptoms showed no significant
difference between the two groups, including fever, cough,
sputum, chest pain and dyspnea between TB DM group and
non-diabetic group, being 67.7% vs. 63.4%, 83.3% vs. 80.5%,
53.3% vs. 65.9%, 46.7% vs. 51.2%, and 33.3% vs. 46.3%,
respectively (p > 0.05).
The TB DM group showed lower incidence of upper lung
lobe (ULL) lesions compared to the TB group (33.3% vs.
43.9%; P < 0.05) and higher incidence of lower lung lobe
Table 1
Lobes and sides affected by pulmonary tuberculosis in DM and NON-DM
groups.
Lobe involved TBDM group (%)
(n ¼ 30)
TB group (%)
(n ¼ 41)
P value
Upper Lobe 10 (33.3) 18 (43.9) P < 0.05
Middle Lobe 1 (3.3) 2 (4.9) P > 0.05
Lower Lobe 9 (30.0) 7 (17.1) P < 0.05
Upper þ Middle 0 (0.0) 5 (12.2) P < 0.01
Middle þ Lower 3 (10.0) 3 (7.3) P > 0.05
Upper þ Middle þ Lower 5 (16.8) 4 (9.8) P > 0.05
Upper þ Lower 2 (6.7) 2 (4.9) P > 0.05
Side affected
Right 7 (23.3) 13 (31.9) P > 0.05
Left 11 (36.7) 17 (41.7) P > 0.05
Bilateral 12 (40.0) 11 (26.8) P > 0.05
Note: p < 0.05 was considered statically significant.
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Table 1).3.2. CT findings in non-diabetic patientsTypical CT signs in bronchogenic spread of pulmonary
tuberculosis included centrilobular branching linear structure,
relatively poorly defined centrilobular peribronchiolar nodules
of 2e3 mm in size, nodules of 5 mm in size, and lobular
consolidations. Satellite lesions, such as small nodular lesions
or slightly increased attenuation surrounding the main lesion,
were found in 26 of 41 patients (63.4%) who had the main CT
patterns of parenchymal abnormalities. Miliary tuberculosis
was the other CT patterns observed in 2 of 41 cases (4.9%). In
these two, small nodular lesions diffusely disseminated in both
lungs by conventional CT scans. Unusual localization of
tuberculosis lesions was found in 7 of the 41 patients (17.1%)
with no underlying disease. In these 7, the lesions were
confined either to the basal segment of the lower lung lobe (2),
the anterior segment of the upper lung lobe (3), or the right
middle lung lobe (2).
Except for those with miliary tuberculosis, almost all pa-
tients (39/41, 95.1%) had segmental distribution. The lesionsFig. 1. A. Plain CT scan of the right hemithorax showed patchy opacities, with infilt
of right upper lung lobe. Fig. 1B. CT scan of the same area after 3 months treatm
revealed almost complete cure of the lesion after routine anti-tuberculous regimenwere confined to a single segment in 27 patients; they occu-
pied multiple segments of one lung in 7 (Fig. 1)and they
occupied multiple segments of both lungs in 7.
A total of 25 patients (25/41,61.3%) showed the bud-in-tree
sign, 17 (17/41,41.7%) showed bronchiectasis, 6 (6/41,15.6%)
showed pleural effusion and 2 (2/41,5.3%) showed tuber-
culoma with smooth and regular margin. In addition, 13 of the
41 (31.7%) had cavitary lesions (including 11 cases of single
cavity and 2 cases of multiple cavities). Lesions could be
singular or multiple. But for all cavitary lesions except in 2
cases, a cavitated lesion contained only a single cavity; in
those two exceptions, multiple small cavities were found
within a single confluent consolidation (Table 2).
By follow-up CT scans, gradual shrinkage of lobular
consolidation, poorly defined nodules, and centrilobular nod-
ules or branching linear lesions were observed in that order.
Resolution of lobular consolidation began commonly at the
periphery, with eventual transformation into a poorly defined
nodule, followed by a centrilobular nodule or branching linear
lesion (Fig. 1C). Centrilobular nodules or branching linear
structures observed on initial CT scans gradually decreased in
prevalence after 6 months of treatment. Compared to the
centrilobular lesions, cavities healed by obliteration with more
residual fibrotic changes (linear or stellate). Ground-glass
pattern was observed for 10 times before treatment, 7 times
after 3 month treatment and only 2 times after 6 month
treatment.
Micronodules were found in 39 (39/41,95.1%) patients
before treatment (Fig. 1A). These micronodules were found all
over the lung parenchyma. These micronodules disappeared
after treatment in 15 of 41 patients (36.6%). Most patients had
residual micronodules, although the number of micronodules
per patient dropped markedly. Nodules were found in 73%
(30/41) of the patients before treatment and the lesions were
detected after treatment in 21 of 41 patients (51.2%). The bud-
in-tree sign was noted in 25 of 41 patients (60.9%) and all
were undetectable after treatment.
Alveolar consolidation was observed in 28 (28/41, 68.3%)
patients before treatment, and the lesion persistently existed in
9 patients (9/41, 21.9%) after treatment. Ground-glass opacityrates, small cavity, peripheral nodules and fibrotic strands in the lateral segment
ent. Fig. 1C. CT scan of the same area after 6 months treatment. Fig. 1BeC
. The images were from a 33-year-old non-diabetic male patient with TB.
Table 2
CT findings before treatment in patients with pulmonary tuberculosis in DM
and NON-DM groups.
CT findings TBDM group (%)
(n ¼ 30)
TB group (%)
(n ¼ 41)
P value
Consolidation 23 (76.7) 28 (68.3) P < 0.05
Satellite Lesion 21 (70.0) 26 (63.4) p > 0.05
Nodules 19 (63.3) 30 (73.2) p > 0.05
Micronodules 27 (90.0) 39 (95.1) p > 0.05
Bud-in-tree sign 13 (43.3) 25 (61.3) P > 0.05
Bronchiectasis 10 (33.3) 17 (41.7) p > 0.05
Ground Glass Opacity 5 (16.7) 10 (24.4) p > 0.05
Single Cavity 6 (20.0) 11 (26.8) p > 0.05
Multiple Cavities 9 (30.0) 2 (4.9) P < 0.01
Lymphadenopathy
Mediastinal Nodes 5 (16.7) 6 (14.6) p > 0.05
Hilar Nodes 3 (10.0) 5 (12.2) p > 0.05
Parenchymal Calcification 5 (16.7) 8 (19.5) p > 0.05
Tuberculoma 0 (0.0) 2 (4.9) P < 0.05
Pleural Effusion 7 (23.3) 6 (15.6) p > 0.05
Unusual Localization 5 (16.7) 7 (17.1) p > 0.05
Nonsegmental distribution 8 (26.7) 1 (2.4) P < 0.01
Miliary TB 1 (3.3) 2 (4.9) p > 0.05
Note:p < 0.05 was considered statically significant.
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was found in only 2 cases (5%) after treatment. In all 10 cases
with ground-glass opacity, the ground-glass pattern was
detected to be localized (Fig. 1C).
Cavities were found in 13 cases (13/41, 31.7%), with 11
cases of singular and 2 cases of multiple lesions. All cavities
were shown with a smooth inner wall and a thick outer wall
(Fig. 1A.). After treatment, the cavities shrank in size with
decreased thickness of the wall (Fig. 1B). The cavities of 10
patients (10/41, 24.4%) were undetectable after treatment
(Fig. 1C), but remained with thinner wall and smaller size in 3
patients (3/41, 7.3%) after treatment.
Bronchiectasis was found in 17 (17/41, 41.5%) patients
before treatment and 20 (20/41, 48.8%) patients after treat-
ment. Lymphadenopathy was observed in 11 (11/41, 26.8%)
patients before treatment, only in 4 patients after treatment.Fig. 2. Plain CT scan of the left hemithorax showed patchy opacities surrounded by
left upper lung lobe. A. Thick-walled cavitary lesion was detected in lateral half w
C. CT scan of the same area after 6 months treatment. BeC Revealed incomplete cu
a 40-year-old diabetic male patient with TB.Only 6 (6/41,14.7%) patients showed pleural effusion before
treatment, and the lesion was completely healed after treat-
ment in all 6 cases (see Table 2).3.3. CT findings in diabetic patientsThe CT patterns in diabetic patients were essentially
similar to those in patients without underlying diseases.
Miliary tuberculosis was found in 1 patient (3%), and non-
segmental distribution of the lesions was observed in 8 pa-
tients (8/30, 26.7%). Fifteen of the 30 (15/30, 50%) diabetic
patients showed cavitary lesions, with 9 (9/30, 30.0%) cases of
multiple small cavities in any given lesion and 6 (6/30, 20.0%)
cases of single cavity in any given lesion (Figs. 3e5). These
cavities were revealed with irregular shapes and small pro-
trusions (Fig. 2A). A peripheral bronchiole connecting to the
cavity was clearly observed in some cases. Satellite lesions,
such as small nodular lesions or slightly increased attenuation
surrounding the main lesion, were detected in 21 (21/30,
70.0%) of 30 patients. Unusual localization of the lesions was
observed in 5 (5/30,16.7%) of the diabetic patients, commonly
at the lower lung lobe (Fig. 6). Diabetic patients also showed a
higher occurrence of non-segmental distribution (p < 0.01)
and multiple cavities in any given lesion (p < 0.01). Thirteen
cases (13/30, 43.3%) showed the bud-in-tree sign, 10 cases
(10/30, 30.0%) bronchiectasis, and 7 (7/30, 23.3%) cases
pleural effusion (see Table 2).
On follow-up CT scans, few changes were detected in
diabetic patients. The healing pattern in diabetic patients was
similar to those in non-diabetics but was slower. Centrilobular
nodules or branching linear structures on initial CT scans
gradually decreased in prevalence after 6 months of treatment.
Cavities were completely healed by obliteration with more
residual fibrotic changes in 4 cases (linear or stellate)
(Fig. 2B,C). In remaining 11 patients, the lesions were smaller
in size with decreased thickness of the wall. Ground-glass
opacity was found in 5 patients before treatment but in 3
cases after treatment. Micronodules were found in 27 (27/30,
90.0%) patients before treatment and were completely cured inGGO, with infiltrates and peripheral fibrotic strands in the lingual segment of
ith a soft tissue opacity. B. CT scan of the same area after 3 months treatment.
re of the lesion after routine anti-tuberculous treatment. The images were from
Fig. 3. Plain CT scan of the chest before treatment showed typical lesions of post-primary pulmonary tuberculosis in both lungs, affecting the apical segment of the
right upper lung lobe and posterior segment of the left upper lung lobe. Consolidation with partial collapse of the posterior segment of left upper lung lobe was
demonstrated. A. Thick-walled cavitary lesion was observable in medial half. B. CT scan of the same area after 3 months treatment. C. CT scan of the same area
after 6 months treatment. BeC. Revealed incomplete cure of the lesion after routine anti-tuberculous regimen especially the lesions at the left side with significant
residual segmental collapse of left upper lung lobe. The images were from a 54-year-old diabetic female patient with TB.
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(19/30) of patients before treatment, which remained in17 of
30 (56.7%) patients after treatment. The bud-in-tree sign was
noted in 13 of 30 (43.3%) patients and was only detectable in
5 patients after treatment.
Consolidation was noted in 23 (23/30, 76.8%) patients
before treatment and was noted in 19 (19/30,63.3%) patients
after treatment (Figs. 3 and 4). Bronchiectasis was found in 10
(10/30, 33.3%) patients before treatment and 12 (12/30,
40.0%) patients after treatment. Lymphadenopathy was noted
in 8 (8/30, 26.7%) patients before treatment and was present in
6 (6/30, 20.0%) patients after treatment. Only 7 (7/30, 23.3%)
patients had pleural effusion before treatment, which was
completely cured in 2 (2/30, 6.7%) cases after treatment and
shrank in size in remaining 5 (5/30, 16.7%) cases (see Table
3).
4. Discussions
The association of tuberculosis and DM has attracted the
attention of clinicians for years. The prevalence of tubercu-
losis in patients with diabetes mellitus can be as high as
19.3e~24.1%, being 2e3 times higher than that in non-
diabetic patients [1,2.9,10]. The prompt initiation of treat-
ment for pulmonary TB is crucial not only for the benefits of
the patients, but also for the control of tuberculosis in the
community. With the present retrospective review and analysisof patients, we aimed to provide information regarding the
clinical and radiographic manifestations of this association.
CT can provide important information for the diagnosis and
management of the disease.
Radiological images of pulmonary tuberculosis have been
described as atypical or unusual among diabetic patients,
mainly to indicate the locations of lesions other than the
common upper lung regions observed in reactivated tubercu-
losis. For instances, an increased occurrence of lower lung
field involvement in diabetic patients has been reported by
some researchers, along with a higher occurrence of multi-
lobar involvement [11e13]. Additionally, it has also been
described that some radiological signs of pulmonary tuber-
culosis are different among diabetic patients, such as a higher
detection rate of cavitary lesions [7,13,14], but no radiological
differences between diabetic and non-diabetic patients with
TB in some other reports [6,8]. Thus, whether diabetic sub-
jects have a radiologically atypical signs of TB is still
controversial.
In present study, the following CT signs of active tuber-
culosis were found in non-diabetic patients. The lesions were
segmentally distributed in 98% of the patients, regardless of
being singular or multiple. Satellite lesions were found in
63.4% of the patients before anti-tuberculous therapy. Cavi-
tation occurred in 26.8% of the cases, mostly with singular
cavity within a given lesion, although these patients may have
more than one lesion and therefore more than one cavity.
Fig. 4. A,B. Plain CT scan of the chest before treatment showed multi-lobar involvement of the right hemithorax, affecting the apical and posterior segments of the
right upper lobe, the apical segment of the right lower lobe. The lung fields were demonstrated with patchy infiltrates, opacities, consolidation and collapse, fibrotic
strands, and pleuritic changes. C. CT scan of the same area after 3 months treatment. D. CT scan of the same area after 6 months treatment by the routine anti-
tuberculous therapy. CeD Revealed incomplete cure of the lesion after treatment especially the lesion in posterior half with significant residual segmental collapse
of right middle lobe and apical segment of right lower lobe in addition to residues of pleuritic changes. The images were from a 48-year-old diabetic male patient
with TB.
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acterization in this group of patients was almost the same as
previously reported [15].
In diabetic patients with active tuberculosis, the following
CT signs were found in our study. Multiple cavities occurredFig. 5. Plain CT scan of the chest before treatment showed multi-segments
affecting all segments of left upper lung lobe. The lung fields were demon-
strated with patchy opacities, infiltrates, consolidation and multiple cavities,
and marked pleuritic changes at the postero-medial part of the chest. The
images were from a 46-year-old diabetic male patient with TB.in 30.0% of the patients within the tuberculous consolidative
lesions, with statistical significance compared to non-diabetic
patients (P < 0.01). Nonsegmental distribution of the lesions
was found in 26.7% of the patients (P < 0.01) and more lowerFig. 6. Plain CT scan of the chest before treatment showed involvement of the
left hemithorax, affecting the apical/posterior segments of left lower lobe. The
lung fields with patchy infiltrates were demonstrated consolidation, thick-
walled cavity, ground glass opacity and multi-nodules. The images were
from a 72-year-old diabetic female patient with TB.
Table 3
CT findings after 6 months treatment in patients with pulmonary tuberculosis
in TB and TBDM groups.
Radiological features TBDM group (%)
(n ¼ 30)
TB group (%)
(n ¼ 41)
P value
Consolidation 19 (63.3) 9 (21.9) P < 0.01
Satellite Lesion 16 (53.3) 5 (12.2) P < 0.01
Nodules 17 (56.7) 16 (39.0) P < 0.05
Micronodules 23 (76.7) 24 (58.5) P < 0.01
Bud-in-tree sign 5 (16.7) 0 (0.0) P < 0.01
Bronchiectasis 12 (40.0) 20 (48.8) p > 0.05
Ground Glass Opacity 3 (10.0) 2 (4.9) p > 0.05
Single Cavity 5 (16.7) 3 (7.3) P < 0.05
Multiple Cavities 6 (20.0) 0 (0.0) P < 0.01
Lymphadenopathy
Mediastinal Nodes 4 (13.3) 2 (4.9) P  0.05
Hilar Nodes 2 (6.7) 2 (4.9) p < 0.05
Parenchymal Calcification 5 (16.7) 8 (19.5) p > 0.05
Tuberculoma 0 (0.0) 2 (4.9) P < 0.05
Pleural Effusion 5 (16.7) 1 (2.4) P < 0.01
Note:p < 0.05 is statically significant.
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(P < 0.05). Many studies have shown a higher rate of cavitary
lesions in diabetics [7,11,16], which are in consistency with
the result of the present study. However, some other studies
were reported with different finding [6,8], which may caused
by different sources of the study subjects. The multiple cav-
ities observed in diabetic patients are believed to be different
from the usual type of cavity found in cases of pulmonary
tuberculosis. In some cases, a peripheral bronchiole connect-
ing to the cavity was clearly observable. In diabetic patients,
unusual localizations such as lesions confined to the basal
segments of the lower lobe, the anterior segment of the upper
lobe, and the medial and lateral segments of the middle lobe
were often described. In our series, unusual localization in the
lower lobes was found with an occurrence of 30.0% in diabetic
group and 17.1% in the non-diabetic group, showing a sig-
nificant difference (p < 0.05). Bilateral and multi-lobar
involvement was also common in our patients in both
groups, which has been shown in other previous studies
[11,12,17e19].
In this study, we found micronodules in 90% of diabetic
patients and 95% of non-diabetic patients. Micronodules are
most often detected in the acute early stage of the active
tuberculosis. They are commonly poorly defined with a ten-
dency to coalesce. The lesions are usually 5 mm in diameter,
and are generally located at the peripheral areas of consoli-
dations or cavities. Micronodules are not observable by stan-
dard chest radiography. Micronodules thus appear to be a
useful diagnostic sign of tuberculosis, and the detection of
these discrete foci is indeed highly suggestive of active
tuberculosis. Poey et al. [20] emphasized that these micro-
nodules can be completely cured after treatment, but in our
study, they could still be found in 77% of diabetic patients and
59% of non-diabetic patients after 6 months treatment, which
is related to low level of immune response in diabetics.
Micronodules on CT scans have been demonstrated to be in-
flammatory lesions in the bronchioles and peribronchiolaralveoli by histologic examination. Itoh et al. [21]. reported that
the disease develops initially in respiratory bronchioles fol-
lowed by surrounding focal inflammation, and these patho-
logical processes contribute the emergence of nodules on
radiological examination of the lung. ImG et al. [22]. reported
that micronodules consisted of solid caseous substances within
or around the terminal or respiratory bronchioles.
The bud-in-tree patterns on CT were firstly used by ImG
et al. [22] to describe the appearance of the endobronchial
spread of M. tuberculosis. It represents a form of bronchiolar
impaction in which branching linear structures have more than
one contiguous branching site [23,24]. Terminal tufts of the
bud-in-tree structure might represent caseation necrosis within
the bronchioles and alveolar ducts, while the stalk might
represent a lesion that affected the last order bronchus within
the secondary lobule [22e26]. This bud-in-tree sign is char-
acteristic but non-specific that cannot help to define the
diagnosis of active tuberculosis. During our study, The bud-in-
tree sign was present in both diabetic patients (61.3%, 25/41)
and non-diabetic patients (43.3%, 13/30) (P > 0.05). It dis-
appeared in non-diabetic patients at the end of 6 months anti-
tuberculous treatment, but remained in 16.7% of diabetic pa-
tients (P < 0.01). In the proper clinical setting, the bud-in-tree
sign is believed to be a reliable sign for the diagnosis of active
disease, and the pattern can be distinguished from old fibrotic
lesions [22,24].
In our study, cavities were found in 50.0% of diabetic pa-
tients and 31.7% of non-diabetic patients, and persisted in
36.7% of diabetic patients and 7.3% of non-diabetic patients
after 6 months treatment (P < 0.01). Cavities could be a
favorable diagnostic sign, but no specific correlation between
the CT appearance of cavities and disease activity has been
demonstrated. Small foci of parenchymal cavitation, both in
areas of confluent pneumonia and in areas of disease associ-
ated with distortion of the underlying lung parenchyma, can be
favorably detected on CT scan.
At the end of anti-tuberculosis therapy the lesions were
slowly absorbed in diabetic patients as compared to non-
diabetic, with a statistical difference (P < 0.05). This sug-
gests that diabetes has a negative impact on the treatment
outcome. Anti-tuberculosis therapy in diabetic patients
showed poor efficacy compared to the non-diabetic patients,
and continuation of the treatment was commonly needed. But
there are also reports showing no significant difference be-
tween diabetic and non-diabetic patients [27,28].
In conclusion, CT manifestations of tuberculosis in diabetic
patients differ from those in non-diabetic patients. Diabetic
patients with tuberculosis have a higher prevalence of non-
segmental distribution, multiple cavities within a tuberculous
lesion and more often occurrence in lower lobe and more than
one lobe involvement than non-diabetic patients with TB. On
follow-up examination, the disappearance of the bud-in-tree
sign, absence of pleural effusion and the presence of fibrotic
changes seem to be indications of therapeutic efficacy. Dia-
betes has a negative impact on treatment outcome and the
resolution of lesions on CT in diabetic patients is slower than
that in non-diabetic patients. CT can provide important
22 H. Wu et al. / Radiology of Infectious Diseases 3 (2016) 15e22information in the diagnosis and management of the disease.
This is particularly helpful in the early treatment of the dis-
eases, because only half of TB patients show acid fast bacilli
positive in their sputum.
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